We can Do Better: Voting in Georgia — Inspiring Critical Thinking and Community via Books, Lessons, and Story

Click to learn more about how to help the voting process in GA, and then, This letter may also be useful once adapted, “The Honorable Your RepYourState House of RepresentativesAddress of State HouseTel: num your nameaddress,city, state zipemailyour phone Dear LawmakerTitle Name, I would like to request a bill which would benefit state residents. The […]

We can Do Better: Voting in Georgia — Inspiring Critical Thinking and Community via Books, Lessons, and Story

Viver

Pensamentos.me/VEM comigo!

Viver é encantar-se todos os dias pela vida, pela lucidez que ela traz, pelo anonimato da beleza que é consumida diante dos nossos olhos, e principalmente, por descobrir como é dantesca a nossa capacidade de amar, e se tiver sorte, ser amado. A vida é simples, não tem segredo. A regra é que, entre o amargo dos fracassos e o lírico que a constrói, a beleza dar-se só naquilo que a gente se permite, ou se apaixona. A verdade é que, qualquer ideia brilha, desde que, ela não seja medíocre, ou vazia.

A vida é movimento, ela precisa se mover o tempo inteiro para termos algum ganho; do contrário, a gente só se acostumar no mesmo lugar de sempre. Não, é preciso aprender, é preciso, se adaptar, agir, reagir, enfrentar o que nos parece ser um desafio. A gente sempre tem que traçar novas rotas para que se perceba que…

View original post 200 more words

Bayer to Pay $40 Million to Resolve the Alleged Use of Kickbacks and False Statements Relating to Three Drugs | OPA | Department of Justice

In a lawsuit filed in the District of New Jersey, Simpson alleged that Bayer paid kickbacks to hospitals and physicians to induce them to utilize the drugs Trasylol and Avelox, and also marketed these drugs for off-label uses that were not reasonable and necessary. Simpson further alleged that Bayer downplayed the safety risks of Trasylol. The lawsuit alleged that as a result of this conduct, Bayer caused the submission of false claims to the Medicare and Medicaid Programs and violated the laws of 20 states and the District of Columbia. Trasylol is a drug used to control bleeding in certain heart surgeries. Avelox is an antibiotic approved to treat certain strains of bacteria.

Simpson filed a second lawsuit relating to Bayer’s statin drug, Baycol, which was later transferred to the District of Minnesota. That lawsuit alleged that Bayer knew about, but downplayed, Baycol’s risks of causing rhabdomyolysis. The lawsuit further alleged that Bayer misrepresented the efficacy of Baycol when compared to other statins and fraudulently induced the Defense Logistics Agency to renew certain contracts relating to Baycol. Subsequently, Trasylol and Baycol were withdrawn from the market for safety reasons.

“Simpson diligently pursued this matter for almost two decades,” said Principal Deputy Assistant Attorney General Brian M. Boynton, head of the Department of Justice’s Civil Division.  “Today’s recovery highlights the critical role that whistleblowers play in the effective use of the False Claims Act to combat fraud in federal healthcare programs.”

“We recognize Simpson for her perseverance with this matter,” said U.S. Attorney Andrew M. Luger for the District of Minnesota. “We are pleased we were able to work with the parties to facilitate this resolution and help bring this longstanding matter to a close.”

Source: Bayer to Pay $40 Million to Resolve the Alleged Use of Kickbacks and False Statements Relating to Three Drugs | OPA | Department of Justice